NIH-funded research R01 grant

Creating advanced treatments for head and neck cancer using implantable devices

Official title: Development and optimization of highly effective treatments in patients with head and neck cancer using in situ implantable microdevices

Funded at Brigham and Women's Hospital · NIH-11027024 · Data updated 2026-11-12

This study is testing new tiny devices that can deliver cancer treatments right to tumors in people with head and neck cancer, helping doctors find the best options for each patient while aiming to improve results and lessen side effects.

More Head and Neck Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 13, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$703,540
NIH project number1R01CA295683-01
Project IDNIH-11027024 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with head and neck cancer who are seeking personalized treatment options.

Less likely to help

Patients with cancers other than head and neck cancer may not benefit from this specific research.

What this research studies

This research focuses on developing innovative implantable microdevices that can deliver small doses of various cancer treatments directly to tumors in patients with head and neck cancer. By measuring how the tumor responds to each treatment, the research aims to identify the most effective therapies tailored to individual patients. This personalized approach could significantly improve treatment outcomes and reduce side effects by ensuring that patients receive the most suitable therapies based on their unique tumor characteristics.

Why it matters

Potential benefit: If successful, this research could lead to more effective and personalized treatment options for patients with head and neck cancer.

How similar studies have gone: Previous research has shown promising results with similar implantable microdevice technologies in predicting treatment responses in other cancer types.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Jonas, Oliver — Brigham and Women's Hospital
  • Study coordinator: Jonas, Oliver

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.